The investigation determined that a lower than expected tsh result was obtained from a single patient sample using vitros tsh reagent lot 6390 on a vitros 5600 integrated system.A definitive assignable cause could not be determined.Based on historical quality control results, a vitros tsh lot 6390 performance issue is not a likely contributor to the event.Furthermore, continual tracking and trending of complaint data has not identified any signals to suggest there is a systemic quality issue with vitros tsh reagent lot 6390.Vitros tsh diagnostic precision testing results processed on the vitros 5600 system were within ortho acceptable guidelines suggesting an instrument issue was not likely a contributing factor of the event.The precision testing was not performed around the time of the event, however, historical qc results around the time of the event were precise indicating that an instrument related issue was not a likely contributor of the event.Pre-analytical sample processing could not be ruled out as a contributing factor as it is unknown if the customer was following the sample collection device manufacturer¿s recommended centrifugation protocol.Improper pre-analytical sample handling could have contributed to the event.It is possible that cellular debris, due to poor sample preparation, was present in the affected sample, although this could not be confirmed.A sample interferent was not able to be confirmed nor ruled out as a contributing factor of the event as no information was provided in regards to whether the patient was taking any medications or vitamin supplements around the time of the event.In addition, testing of the sample using heterophilic antibody blocking tubes was unable to be completed as no sample remains for further testing.Email address for contact office above is (b)(4).
|